Creative Medical Technology Holdings, Inc. (CELZ) Institutional Ownership

Ownership Summary

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) showed up in the 13F filings of 14 institutional investors as of December 2025.

• These investors held 5.0% of outstanding shares in December 2025, up from 2.7% in September 2025.
• They increased total shares held in Creative Medical Technology Holdings by 96.27% from last quarter, and the number of investors in CELZ increased 55.56% annually.
• Of these 14 holders, 8 added to their stakes in Creative Medical Technology Holdings, 1 trimmed positions, and 5 made no changes.
• In total, institutional investors held 128.86K shares in Creative Medical Technology Holdings as of December 2025, up by 63.21K shares quarter on quarter, and up 98.85K shares year over year.
• As of December 31, 2025, JANE STREET GROUP, LLC held the largest stake in Creative Medical Technology Holdings with 30.2K shares, accounting for 1.17% of total shares outstanding.
• The most significant purchases of CELZ for the quarter ending December 2025 came from JANE STREET GROUP, LLC (30.2K), CITADEL ADVISORS LLC (17.46K), Global Retirement Partners, LLC (7.92K), GEODE CAPITAL MANAGEMENT, LLC (5.21K), Bank Of America Corp /De/ (4.87K).
• The largest sellers of Creative Medical Technology Holdings for the quarter ending December 2025 were DRW Securities, LLC (4.78K).
• Business Quant data shows the 10 biggest positions in Creative Medical Technology Holdings as of December 2025 are held by JANE STREET GROUP, LLC (30.2K), GEODE CAPITAL MANAGEMENT, LLC (28.47K), VANGUARD GROUP INC (25.87K), CITADEL ADVISORS LLC (17.46K), DRW Securities, LLC (10.32K), Global Retirement Partners, LLC (7.92K), Bank Of America Corp /De/ (5.13K), Tower Research Capital LLC (TRC) (2.32K), OSAIC HOLDINGS, INC. (1.13K), Morgan Stanley (34).